CHF Solutions (NSDQ:CHFS) announced today that it initiated distribution agreements with Neucomed Group and its affiliates to cover Germany, Austria and Switzerland.

With the new distribution agreements, Eden Prairie, Minn.–based CHF Solutions is further expanding its commercial presence in Europe, as the company now has distribution partnerships covering 13 different countries across the globe, according to a news release.

CHF Solutions develops the Aquadex FlexFlow system designed to remove excess fluid from patients suffering from fluid overload. It is indicated for temporary (up to eight hours) of ultrafiltration treatment for patients who have failed diuretic therapy and for extended (more than eight hours) in patients who failed diuretic therapy and require hospitalization.

“We continue to execute on our goal to expand worldwide access to aquapheresis therapy,” CHF Solutions chairman John Erb said in the news release. “With the recently-announced receipt of the CE Mark for our next generation Aquadex SmartFlow console, we are able to provide this simple, flexible and smart solution to patients in the EU suffering from fluid overload due to heart failure, cardiovascular surgery and other critical care conditions and are looking forward to working with Neucomed.”